NEBIUS
✦ StockVane Quant Insights how this is computed
- Twelve-month momentum in the top 9% of the universe, above its 200-day average.
- Signal has read BUY for 6 months.
- Recent price momentum is +34.5% on average (3-month/1-year).
- Main-fund capital flow has been a net inflow over the last 45 sessions.
- Analyst tilt is Buy.
- Price is below its 20-day average and above its 60-day average.
- The 20-day average is above the 60-day average, a short-term uptrend.
Computed by a StockVane algorithm from historical price, valuation and analyst data - not a person, not a forecast guarantee, and not investment advice.
Factor grades
Ranked against 977 U.S. stocks StockVane covers.
Valuation F
How expensive the stock is versus earnings, sales and its own 5-year history.
| P/E (TTM) | 323.0x | Better than 1% |
| Price / Sales | 45.0x | Better than 3% |
| P/E vs own 5-yr range | 94th pctl | Better than 7% |
Growth B+
How fast revenue, profit and free cash flow are compounding.
| Revenue CAGR (3Y) | 239.8% | Better than 100% |
| Net income CAGR (3Y) | -52.0% | Better than 2% |
| Free cash flow CAGR (3Y) | 90.4% | Better than 92% |
Profitability C
How much profit the business keeps from each dollar of sales and capital.
| Gross margin | 68.6% | Better than 82% |
| Operating margin | -115.5% | Better than 2% |
| Net margin | 15.6% | Better than 64% |
| Return on equity | 2.1% | Better than 17% |
| Return on invested capital | 1.6% | Better than 17% |
Momentum A
Recent price strength, skipping the latest month to avoid short-term noise.
| 3-month return | 19.2% | Better than 87% |
| 6-month return | 98.1% | Better than 96% |
| 12-month return (ex latest month) | 81.2% | Better than 91% |
| Distance below 52-week high | 22.4% | Better than 42% |
Financial Health D
Balance-sheet strength: leverage, liquidity and interest coverage.
| Current ratio | 3.1x | Better than 82% |
| Debt to assets | 108.3% | Better than 10% |
| Interest coverage | 1.2x | Better than 15% |
| Free cash flow / net income | 31.6% | Better than 8% |
Analyst View B+
What the Street thinks: share of Buy ratings and upside to the average target.
| Analysts rating Buy | 80.0% | Better than 58% |
| Upside to average target | 40.0% | Better than 74% |
Grades are relative rankings, not forecasts: A+ is the top 5% of the covered stocks on a factor, F the bottom 3%. Valuation is not adjusted for sector, so capital-light software tends to grade lower there than utilities. Recomputed every 6 hours from our market data. Not investment advice, and not tailored to your financial situation, goals, or risk tolerance.
Price chart
Anonymous reader poll. Unscientific, not investment advice.
Performance
Key statistics
Price & volume
- Prev close
- 219.71
- Open
- 222.30
- Day range
- 218.50 - 225.30
- Avg price
- 221.54
- Volume
- 9.56M
- Turnover
- 2.12B
- Turnover ratei
- 4.22%
- Volume ratioi
- 0.54
- Amplitudei
- 3.10%
- 52-week rangei
- 73.52 - 299.86
Valuation
- P/Ei
- 669.91
- P/E (TTM)i
- 307.04
- P/Bi
- 5.81
- EPSi
- 0.33
- Book value / shi
- 38.03
- Net profit
- 89.71M
- Net assets
- 10.34B
Share structure
- Market cap
- 60.10B
- Float capi
- 50.05B
- Shares out
- 271.86M
- Float sharesi
- 226.41M
Dividend & listing
- Div yield (TTM)i
- 0.00%
- Dividend (TTM)
- 0.00
- Listing date
- 1970-01-01
26.3% below the 52-week high
Trading activity
Net capital flow main funds, last 45 sessions
+161.49M net over the window
Short interest
- Shares short
- 46.78M
- % of floati
- 17.21%
- Days to coveri
- 3.60
- As of
- 2026-09-15
Frequently asked questions
What is the current stock price of NEBIUS (NBIS)?
NEBIUS last traded at 221.07. The quote on this page refreshes every few seconds while US markets are open.
What is NEBIUS's market cap?
About 60.10B.
What is the P/E ratio of NEBIUS?
The trailing twelve-month P/E is 307.04, above its own 5-year average of 70.42 — toward the top of its historical range (93.56% percentile). See the Valuation tab for the full history.
Does NEBIUS pay a dividend?
NEBIUS does not currently pay a regular dividend.
Is NEBIUS a buy according to analysts?
The consensus of 12 analysts is a Buy rating, with an average 12-month price target of 323.11, which implies 46.2% upside from the current price. This is not investment advice.
What is NEBIUS's StockVane Quant Rating?
The StockVane Momentum strategy currently rates NEBIUS a B (Buy). Twelve-month momentum in the top 9% of the universe, above its 200-day average. Not investment advice.
Quote time 2026-10-09 20:02:39 · For reference only, not investment advice and not tailored to your situation.
NEBIUS discussion 0 comments